Compare SFIX & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SFIX | DNA |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 583.4M | 607.1M |
| IPO Year | 2017 | N/A |
| Metric | SFIX | DNA |
|---|---|---|
| Price | $3.28 | $8.96 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 2 |
| Target Price | $6.00 | ★ $10.50 |
| AVG Volume (30 Days) | ★ 2.0M | 1.1M |
| Earning Date | 03-10-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,290,480,000.00 | $180,606,000.00 |
| Revenue This Year | $7.80 | N/A |
| Revenue Next Year | $3.07 | $3.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.60 | $5.00 |
| 52 Week High | $5.94 | $17.58 |
| Indicator | SFIX | DNA |
|---|---|---|
| Relative Strength Index (RSI) | 22.41 | 46.77 |
| Support Level | $4.85 | $8.65 |
| Resistance Level | $4.19 | $9.61 |
| Average True Range (ATR) | 0.32 | 0.79 |
| MACD | -0.16 | -0.04 |
| Stochastic Oscillator | 0.62 | 44.15 |
Stitch Fix Inc offers personal style services for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandise with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types, and price points including Women's, Petite, Maternity, Men's, and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry, and handbags and sells merchandise across various ranges of price points.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.